Intellia Therapeutics, Inc. · 12 hours ago
Regional Scientific Director, Southern California Region
Intellia Therapeutics, Inc. is dedicated to developing curative genome editing treatments for severe diseases. The Regional Scientific Director will engage with healthcare professionals to provide scientific education on CRISPR gene editing programs and support clinical trial activities in the Southern California region.
BiotechnologyGeneticsHealth CareMedicalTherapeutics
Responsibilities
Engagement with KOLs across ATTR amyloidosis and HAE within territory to provide education on our CRISPR gene editing platform and reactively educate on the MoA and clinical data on nex-z and lonvo-z
Understanding of patient journey at key centers and identification of site capabilities and preferences regarding gene editing
Development of individualized scientific engagement plans for key KOLs aligned with scientific narrative and medical strategy
Identify external insights and knowledge gaps through listening for key intelligence topics of interest and timely reporting via CRM
Medical Congress attendance to enable KOL engagement, medical booth staffing, scientific session coverage, insights gathering and reporting
Institutional presentations on Intellia scientific evidence, as appropriate
Provide scientific support for Phase 3 clinical trials during site start up, activation and recruitment through scientific education and operational insights
Establish, cultivate, and maintain scientific relationships with Investigators and study site teams
Identify barriers to site activation and/or patient recruitment, and discuss solutions with Investigators, study site teams, and institutional administrative team members to address and remove these barriers
Escalate site feedback or concerns to Intellia clinical teams
Develop a robust understanding of clinical practice and referral associated with gene editing therapies
Ensure compliance and high level of scientific integrity in all interactions, including completion of trainings on time and adherence to policies
Qualification
Required
Demonstrated success working in a highly matrixed, cross-functional environment
Ability to critically assess situations to prioritize the importance, urgency and risks, and present leadership with recommendations
Ability to anticipate change and to flexibly adapt to changing business needs
Self-starter and team player with a collaborative spirit and results orientation
Organized, able to multi-task to meet timelines in a fast-paced environment with strong attention to accuracy and detail
Excellent presentation, communication, and project management skills across a variety of interaction mediums including in person, digital, email, phone, etc
Ability to understand and clearly and effectively communicate complex scientific and medical information to both internal and external stakeholders
Excellent written and oral communication skills are imperative; strong interpersonal skills commensurate with the need to collaborate closely with partners, investigators, contractors, consultants, and team members across functions
Established track record of effective and influential oral presentations to both large and small audiences within the healthcare profession
Ability to complete required training, documentation, expense reporting, and other administrative tasks
Willingness and ability to travel 50-70% including overnight stays
Ability to manage a geographically assigned territory from a home-based office
Computer skills including Excel, Word, Power Point, Outlook, and programs such as Zoom are expected
Valid driver's license
Doctorate level or terminal degree (Pharm.D., Ph.D., M.D. or D.O.)
3+ years industry or related field experience
Extensive clinical trial experience including Phase 3 trials
Prior pharmaceutical industry experience as a MSL/RSD with solid understanding of scientific exchange in the context of compliance/ regulated environment and robust experience supporting execution of clinical trial
Preferred
Therapeutic knowledge in allergy/immunology/HAE, cardiology/ATTR-CM/-PN, or genetic medicine highly preferred
New product launch experience highly preferred
Benefits
Performance-based annual cash bonus
New hire equity grant
Eligibility to be considered for annual equity awards
Company
Intellia Therapeutics, Inc.
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
H1B Sponsorship
Intellia Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (38)
2023 (63)
2022 (46)
2021 (10)
2020 (6)
Funding
Current Stage
Public CompanyTotal Funding
$1.54BKey Investors
OrbiMed
2022-11-30Post Ipo Equity· $300M
2021-06-30Post Ipo Equity· $690M
2020-11-30Post Ipo Equity· $201M
Leadership Team
Recent News
Labiotech UG
2026-01-22
Clinical Trials Arena
2026-01-16
Company data provided by crunchbase